The Northern Hemisphere Flu vaccine has arrived for the 2023/2024 Northern Hemisphere Influenza season.
It covers the following strains:
- A/Victoria/4897/2022 (H1N1)pdm09-like virus;
- A/Darwin/9/2021 (H3N2)-like virus;
- B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
- B/Phuket/3073/2013 (B/Yamagata lineage)-like a virus.
The 2023 Southern Flu vaccine did not have the Influenza A/Victoria (H1N1) strain.
It is especially important for the following groups to receive the vaccine as they are more vulnerable to complications of influenza:
- Persons aged 65 years or older
- Children aged 6 months to under 5 years
- Women at all stages of pregnancy
- Adults and children who have chronic diseases, including asthma, diabetes and other chronic diseases of the heart, lungs, liver, kidneys, brain or blood or have a compromised immune system
- Children and adolescents aged six months to 18 years who are receiving long-term aspirin therapy
Other people who should receive the vaccine are:
- Persons receiving intermediate and long-term care (ILTC) services in institutional settings and
- All healthcare workers
- Travelers headed to winter destinations
However, even healthy individuals can get seriously ill from the flu, so everyone is encouraged to get this vaccine.